Module 3: Monitoring and Modifying Cancer Treatment Care Plans
Course Description
This module demonstrates the pharmacists' patient care process in the development and implementation of the monitoring associated with a cancer treatment care plan. Patient-specific monitoring plans integrating basic pharmacology knowledge and evaluation of laboratory and other clinical data, such as pharmacogenomics, biomarkers, physical examination, radiographic, pathologic, and other diagnostic tests, will be discussed. An overview of how to approach drug and cancer-related symptom assessments to further modify plans is provided. Additionally, long-term toxicities associated with anticancer treatments are discussed and examples of how to evaluate, monitor, and treat these is included. Both during-treatment and post-treatment (i.e., survivorship) monitoring plans are discussed and examples are provided.
Learning Objectives
- Identify laboratory and other clinical data required to assess the effectiveness and safety of a cancer treatment care plan
- Formulate patient-specific monitoring plans based on evaluation of laboratory and other clinical data for initial and subsequent cancer treatments
- Recognize drug-related and cancer-related symptoms
- Modify a cancer treatment care plan based on patient-specific laboratory and other clinical data
- Prepare a survivorship care plan given patient-specific information
This module includes a Pre-Test, Content, Post-Test, and Module Evaluation. You must complete all of these module activities, in order, before claiming ACPE credits.
Presenter
Dr. Holle completed her Bachelor of Science in Pharmacy and post-baccalaureate Doctor of Pharmacy from the University of Wisconsin-Madison. She completed a specialized oncology residency at UT M.D. Anderson Cancer Center, and is a board-certified oncology pharmacist. Dr. Holle has worked as an oncology pharmacist for over 25 years in a variety of settings including private hospitals, academic medical centers, and medical communications. Currently, Dr. Holle is an Associate Professor (CHS) at the University of Wisconsin (UW)-Madison School of Pharmacy. Most recently she has worked in a team-based ambulatory care clinic focusing on genitourinary and gastrointestinal cancers.
Dr. Holle is a Past President of the Hematology/Oncology Pharmacy Association (HOPA) and a past Secretariat member and past Treasurer of the International Society of Oncology Pharmacy Practitioners (ISOPP). She is also an active member in many other professional oncology and pharmacy organizations and is currently a HOPAmbassador. Dr. Holle's clinical research program focuses on numeracy and patient decision-making, oncology quality improvement initiatives, medical marijuana, and oral anticancer therapy management. Dr. Holle is a co-editor of the major U.S. textbook in pharmacy education "DiPiro's Pharmacotherapy: A Pathophysiologic Approach" and has co-edited the textbook "Cancer Therapy Prescribing and Administration Basics." She has authored numerous articles and chapters on oncology and teaching-related topics.
Get it here!
Application Course for Pharmacists
HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To claim ACPE Credits the learner must complete all required activities, including the pre- and post-tests, and course evaluation. CE's will be reported within 1-2 weeks of completion of the credit claim activity.
Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.